King's College London

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">King's College London</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>King's College London campus</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>London, United Kingdom</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Research University</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.kcl.ac.uk" target="_blank">kcl.ac.uk</a></td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1829</td>
</tr>
<tr>
<td class="label">Notable Schools</td>
<td>Institute of Psychiatry, Psychology & Neuroscience (IoPPN)</td>
</tr>
<tr>
<td class="label">Students</td>
<td>~32,000</td>
</tr>
<tr>
<td class="label">Researchers at IoPPN</td>
<td>Over 1,200</td>
</tr>
</table>

King's College London

Introduction

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">King's College London</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>King's College London campus</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>London, United Kingdom</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Research University</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.kcl.ac.uk" target="_blank">kcl.ac.uk</a></td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1829</td>
</tr>
<tr>
<td class="label">Notable Schools</td>
<td>Institute of Psychiatry, Psychology & Neuroscience (IoPPN)</td>
</tr>
<tr>
<td class="label">Students</td>
<td>~32,000</td>
</tr>
<tr>
<td class="label">Researchers at IoPPN</td>
<td>Over 1,200</td>
</tr>
</table>

King's College London

Introduction

King's College London is a public research university located in London, England. Founded in 1829 by King George IV and the Duke of Wellington, it is one of the oldest universities in England and one of the world's leading institutions for brain research. King's is home to the Institute of Psychiatry, Psychology & Neuroscience (IoPPN)—one of the largest neuroscience research centers in Europe—and hosts a site of the UK Dementia Research Institute (UK DRI) [kcl1][kcl2].

The university's contribution to neurodegenerative disease research spans basic science discoveries in protein aggregation, biomarker development, clinical trials, and translation of basic neuroscience into clinical applications. King's researchers have made fundamental contributions to understanding [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), frontotemporal dementia, and psychiatric disorders [kcl4].

Organizational Structure

Institute of Psychiatry, Psychology & Neuroscience (IoPPN)

The IoPPN at King's College London is one of the world's leading centers for brain research. With over 1,200 researchers and an annual research budget exceeding £100 million, the institute is dedicated to understanding the brain and improving mental health and neurological care [kcl1].

Major Departments

• Department of Neuroscience: Basic and translational neuroscience research
• Department of Psychological Medicine: Mood disorders, anxiety, and related conditions
• Department of Neuroimaging: Advanced neuroimaging techniques and analysis
• Department of Psychological and Systems Sciences: Computational and systems neuroscience

Research Themes

• Neurodegeneration and dementia
• Psychiatric genetics and neuroscience
• Neuroimaging and biomarkers
• Clinical trials and translation

UK DRI at King's

The UK Dementia Research Institute at King's is a £150 million flagship research center focused on understanding the biological mechanisms underlying dementia and developing new treatments [kcl2].

Research Programs

• Protein Misfolding: Understanding how proteins like tau and alpha-synuclein aggregate
• Cellular Stress: Mitochondrial dysfunction, ER stress, and protein quality control
• Neuroinflammation: Role of microglia and immune responses in neurodegeneration
• Biomarkers: Developing markers for early diagnosis and disease monitoring

Research Programs

Alzheimer's Disease Research

King's College London leads major research programs on Alzheimer's disease:

Biomarker Development

• CSF Biomarkers: Development and validation of cerebrospinal fluid markers for early detection [kcl7]
• Blood Biomarkers: Ultra-sensitive assays for plasma tau, amyloid, and neurofilament light
• Neuroimaging: PET and MRI biomarkers for amyloid, tau, and neurodegeneration

Tau and Amyloid Mechanisms

• Tau Biology: Understanding tau phosphorylation, aggregation, and propagation
• Amyloid Processing: APP processing and amyloid-beta generation
• Oligomer Research: Characterizing toxic soluble oligomers

Clinical Trials

• Immunotherapy trials (anti-amyloid, anti-tau antibodies)
• Small molecule inhibitors
• symptomatic treatments

Parkinson's Disease Research

The IoPPN has major programs on Parkinson's disease and related disorders [kcl8]:

Alpha-Synuclein Biology

• Aggregation Mechanisms: How alpha-synuclein forms Lewy bodies
• Propagation: How pathology spreads through the nervous system
• Therapeutic Targets: Antibodies and small molecules targeting alpha-synuclein

LRRK2 Research

• Kinase Biology: Understanding LRRK2 function and pathogenic mechanisms
• Inhibitor Development: Development of LRRK2 kinase inhibitors

Clinical Research

• Deep Brain Stimulation: Research on DBS for PD
• Non-motor Symptoms: Sleep, autonomic, and cognitive dysfunction in PD
• Biomarkers: Development of PD progression markers

Frontotemporal Dementia Research

King's is a world leader in frontotemporal dementia (FTD) research [kcl2]:

TDP-43 Proteinopathy

• TDP-43 Biology: Understanding TDP-43 aggregation and toxicity [kcl12]
• FTD Genetics: Identification of genetic risk factors
• FTD Subtypes: Understanding clinical heterogeneity

Other Proteinopathies

• FUS: Fused in sarcoma protein in FTD
• Tau: Tau pathology in FTD

Psychiatric Research

King's is a world leader in psychiatric research with relevance to neurodegeneration:

Schizophrenia

• Neuroimaging: Brain structure and function in schizophrenia [kcl11]
• Genetics: Genome-wide association studies
• Neurotransmission: Dopamine and glutamate systems

Depression and Anxiety

• Treatment Response: Predictors of antidepressant response
• Neurobiology: Neural circuits underlying mood disorders

Key Researchers and Leadership

Senior Faculty

Professor Sir John O'Brien

• Biomarker development for early diagnosis
• Neuroimaging in aging and dementia
• Clinical trials for AD therapeutics

Professor Oliver Howes

• Dopamine dysfunction in psychosis
• Neuroimaging studies
• Treatment development

Dr. Rita Sattler

• TDP-43 biology and toxicity
• FTD mechanisms
• Therapeutic target identification

Professor Steven Williams

• Neurodegeneration mechanisms
• Protein aggregation
• Therapeutic development

Major Research Centers and Facilities

Maurice Wohl Clinical Neuroscience Institute

The Maurice Wohl Clinical Neuroscience Institute is a £45 million state-of-the-art research facility housing [kcl3]:

• Advanced laboratory space
• Clinical research facilities
• Imaging equipment
• Training facilities

NIHR Maudsley Biomedical Research Centre

The NIHR Maudsley Biomedical Research Centre is a partnership between King's and South London and Maudsley NHS Foundation Trust, providing [kcl5]:

• Clinical translation infrastructure
• Patient recruitment for studies
• Clinical trials expertise
• Data science capabilities

King's College Hospital

King's College Hospital is a leading NHS neuroscience center providing [kcl9]:

• Clinical services for neurodegenerative diseases
• Patient access to research studies
• Clinical trial infrastructure

Neuroimaging Centre

King's has state-of-the-art neuroimaging facilities including [kcl13]:

• 3T MRI Scanner: High-resolution brain imaging
• 7T MRI: Ultra-high field imaging
• MR-PET: Combined imaging capabilities
• PET Scanners: Amyloid, tau, and neurotransmitter PET

King's Brain Bank

The King's Brain Bank provides post-mortem brain tissue for research, supporting [kcl20]:

• Neuropathology studies
• Biomarker validation
• Disease mechanism research

Notable Discoveries and Contributions

Historical Milestones

| Year | Discovery | Researchers |
|------|-----------|-------------|
| 1960s | Early work on neurotransmitters | Multiple King's researchers |
| 1990s | Psychiatric genetics studies | IoPPN groups |
| 2000s | Neuroimaging biomarkers | O'Brien, others |
| 2010s | TDP-43 research | Sattler, others |
| 2015 | UK DRI at King's established | King's/MRC partnership |
| 2020 | Blood biomarker development | King's groups |

Current Research Focus

Biomarkers

• Blood Tests: Ultra-sensitive detection of neurodegeneration markers [kcl7]
• Imaging: PET and MRI biomarkers for diagnosis and progression
• CSF: Cerebrospinal fluid markers

Disease Mechanisms

• Protein Aggregation: Tau, alpha-synuclein, TDP-43
• Neuroinflammation: Microglial activation
• Cellular Stress: Mitochondria, ER stress

Therapeutics

• Immunotherapies: Antibody development
• Small Molecules: Kinase inhibitors, modulators
• Cell Therapy: Stem cell approaches [kcl16]

Training and Education Programs

King's College London offers extensive training in neuroscience and neurodegeneration [kcl14][kcl15]:

Graduate Programs

• MSc in Neuroscience: Comprehensive neuroscience training
• MSc in Clinical Neuroscience: Clinical-focused training
• MSc in Dementia: Dementia-specific program
• MSc in Translational Neuroscience: Translation-focused training

Research Programs

• MRC DTP in Neuroscience: PhD training program
• Wellcome Trust PhD in Mental Health Research: Mental health-focused PhD
• King's Postdoctoral Fellowships: Research training

Clinical Training

• Neurology Residency: Clinical training
• Old Age Psychiatry Fellowship: Dementia-focused training
• Movement Disorders Fellowship: PD and related disorders
• Cognitive Neurology Fellowship: Cognitive disorders

Short Courses

• Neuroimaging Workshop: MRI and PET analysis
• Clinical Trial Design: Trial methodology
• Data Science: Computational neuroscience

International Collaborations

King's College London maintains extensive international research partnerships:

North American Partnerships

• Harvard/MIT Broad Institute: Psychiatric genetics [kcl1]
• National Institute of Mental Health (NIMH): Psychiatric research
• University of California: Multiple collaborations

European Collaborations

• European Alzheimer's Disease Consortium: AD genetics and biomarkers
• European Consortium for Alzheimer's Disease: Collaborative research
• Karolinska Institutet: Swedish partnership

Global Networks

• India Partnerships: Research collaboration with Indian institutions
• African Research: Global health partnerships
• Asia-Pacific: Multiple regional collaborations

Funding and Investment

King's College London's neurodegeneration research is supported by:

Major Funding Sources

• Medical Research Council (MRC): Core UK DRI funding
• National Institute for Health Research (NIHR): Clinical research infrastructure
• Wellcome Trust: Project grants and fellowships
• Alzheimer's Research UK: Disease-specific funding
• Alzheimer's Society: Patient-focused research
• European Research Council: Horizon Europe funding

Strategic Investment

The university has committed significant internal funding:

• UK DRI: £150M investment in dementia research
• Maurice Wohl Institute: £45M facility
• Neuroimaging: Advanced imaging infrastructure

Future Directions

King's College London has outlined major strategic priorities for neurodegeneration research:

The IoPPN at King's remains at the forefront of translating basic neuroscience discoveries into clinical applications for patients with neurodegenerative diseases.

See Also

• [Universities Index](/universities)
• [UK Dementia Research Institute](/institutions/uk-dementia-research-institute)
• [Institute of Psychiatry, Psychology & Neuroscience](/institutions/ioppn)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
• [Tau Protein](/proteins/tau)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [TDP-43](/proteins/tdp-43)
• [Imperial College London](/institutions/imperial-college-london)
• [University College London](/institutions/university-college-london)

References